Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Alfa Dosing Schedules in Chemotherapy-Induced Anemia
NCT00416624Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- May 2007
- Primary completion
- Jun 2009
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa, sponsored by Mayo Clinic. Started May 2007; status: completed.
02
Drugs
epoetin alfa
Beyond the preview
Go deeper on NCT00416624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00416624.